The Petrovski et al. findings and the present study pediatric outcomes, where Auto Correction insulin averaged 19% of TDD and 31% of total bolus, shed light on how ICR adjustments and specific modifiable settings inherent to AID therapy can help children and adolescents who may have difficulty managing hyperglycemia when compared to adults. This evidence concerns the gene INS and Hyperglycemia.